Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.290
-0.080 (-5.84%)
At close: Sep 5, 2025, 4:00 PM
1.350
+0.060 (4.65%)
After-hours: Sep 5, 2025, 6:42 PM EDT
Vivani Medical Employees
Vivani Medical had 37 employees as of December 31, 2024. The number of employees decreased by 7 or -15.91% compared to the previous year.
Employees
37
Change (1Y)
-7
Growth (1Y)
-15.91%
Revenue / Employee
n/a
Profits / Employee
-$690,189
Market Cap
76.42M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37 | -7 | -15.91% |
Dec 31, 2023 | 44 | -6 | -12.00% |
Dec 31, 2022 | 50 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VANI News
- 2 days ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire
- 17 days ago - Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 - GlobeNewsWire
- 24 days ago - Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 4 months ago - Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - GlobeNewsWire
- 5 months ago - Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - GlobeNewsWire
- 5 months ago - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire